← SynDRA
HALOBETASOL PROPIONATE
SynDRA canonical compound SYN0023269 — structure-anchored drug synonym record
| Clinical phase | Launched |
| Approval status | Approved · Rx/OTC |
| Primary target(s) | NR3C1 | PLA2G1B |
| Mechanism of action | glucocorticoid receptor agonist |
| Indication | corticosteroid-responsive dermatoses |
| Disease area | dermatology |
All known targets
- NR3C1
- ESRRA; ESRRB; ESRRG
- PLA2G1B
Mechanisms of action (all sources)
Drug classes
- Cardiovascular Agents
- Vasoconstrictor Agents
ATC classes
- D07A · CORTICOSTEROIDS, PLAIN
- ANTIPSORIATICS FOR TOPICAL USE
Cross-references
Synonyms
- ulobetasol propionate
- miracorten
- Ulobetasol
- Ulobetasol propionate
- 21-chloro diflorasone
- Halobetasol
- Jemdel
- BMY-30056
- CGP-14,458
- CGP-14458
- IDP-122
- Bryhali
- Halobetasol propionate component of duobrii
- Halobetasol propionate component of idp-118
- Lexette
- Ultravate
- Miracorten
- Halobetasol propionate [USAN]
- Ulobetasol cream
- CGP 14 458
- Halobetasol propionate (USAN)
- Ultravate (TN)
- [(6S,9R,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
- [(6S,8S,9R,10S,11S,13S,14S,16S,17R)-17-(2-chloroacetyl)-6,9-difluoro-11-hydroxy-10,13,16-trimethyl-3-oxo-6,7,8,11,12,14,15,16-octahydrocyclopenta[a]phenanthren-17-yl] propanoate
- 21-Chloro-6alpha,9-difluoro-11beta,17-dihydroxy-16beta-methylpregna-1,4-diene-3,20-dione 17-propionate
- 6 alpha-fluoroclobetasol 17-propionate
- 6-fluoroclobetasol 17-propionate
- halobetasol.propionate
- Halobetasol (propionate)
- BMY 30056
- 91A0K1TY3Z
- UNII-91A0K1TY3Z
- NCGC00167451-01
- Halobetasol propionate [USAN:USP]
- BRYHALI
- BMY-30056;CGP-14458;Ulobetasol propionate
- SCHEMBL33858
Look up HALOBETASOL PROPIONATE in the interactive SynDRA portal →